This is the first clinical trial of the scaffold, which is intended for spinal cord injury treatments. The first clinical site selected is The University of Arizona Medical Center in Tucson.
The pilot study has been approved by the U.S. Food and Drug Administration.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
